Brian Spurlock

Dr. Brian Spurlock

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2024 in Science Advances
Verified
Journal Article
Open access
YDYanhan Dong
Yanhan Dong
Yuchen YangYuchen Yang
Yuchen Yang
HWHAOFEI WANG
HAOFEI WANG
DFDong Feng
Dong Feng
ENElizabeth Nist
Elizabeth Nist
Jiandong LiuJiandong Liu
Jiandong Liu
Cardiac regeneration requires coordinated participation of multiple cell types whereby their communications result in transient activation of proregenerative cell states. Although the molecular characteristics and lineage origins of these activated cell states and their contribution to cardiac regeneration have been studied, the extracellular signaling and the intrinsic genetic program underlying the activation of the transient functional cell states remain largely unexplored. In this study, we delineated the chromatin landscapes of the noncardiomyocytes (nonCMs) of the regenerating heart at the single-cell level and inferred the cis-regulatory architectures and trans-acting factors that control cell type–specific gene expression programs. Moreover, further motif analysis and cell-specific genetic manipulations suggest that the macrophage-derived inflammatory signal tumor necrosis factor–α, acting via its downstream transcription factor complex activator protein–1, functions cooperatively with discrete transcription regulators to activate respective nonCM cell types critical for cardiac regeneration. Thus, our study defines the regulatory architectures and intercellular communication principles in zebrafish heart regeneration.

21 September 2021 in eLife
Verified
Journal Article
Open access
BSBrian Spurlock
Brian Spurlock
DPDanitra Parker
Danitra Parker
MBMalay Kumar Basu
Malay Kumar Basu
AHAnita Hjelmeland
Anita Hjelmeland
SGSajia GC
Sajia GC
KMKasturi Mitra
Kasturi Mitra
Gene knockout of the master regulator of mitochondrial fission, Drp1, prevents neoplastic transformation. Also, mitochondrial fission and its opposing process of mitochondrial fusion are emerging as crucial regulators of stemness. Intriguingly, stem/progenitor cells maintaining repressed mitochondrial fission are primed for self-renewal and proliferation. Using our newly derived carcinogen transformed human cell model, we demonstrate that fine-tuned Drp1 repression primes a slow cycling ‘stem/progenitor-like state’, which is characterized by small networks of fused mitochondria and a gene-expression profile with elevated functional stem/progenitor markers (Krt15, Sox2 etc) and their regulators (Cyclin E). Fine tuning Drp1 protein by reducing its activating phosphorylation sustains the neoplastic stem/progenitor cell markers. Whereas, fine-tuned reduction of Drp1 protein maintains the characteristic mitochondrial shape and gene-expression of the primed ‘stem/progenitor-like state’ to accelerate neoplastic transformation, and more complete reduction of Drp1 protein prevents it. Therefore, our data highlights a ‘goldilocks’ level of Drp1 repression supporting stem/progenitor state dependent neoplastic transformation.

11 October 2024 in Cells
Verified
Journal Article
Open access
PDF file
YSYiran Song
Yiran Song
BSBrian Spurlock
Brian Spurlock
Jiandong LiuJiandong Liu
Jiandong Liu
Li QianLi Qian
Li Qian
Cardiovascular diseases are a leading cause of mortality worldwide, and the risks of both developing a disease and receiving a poor prognosis increase with age. With increasing life expectancy, understanding the mechanisms underlying heart aging has become critical. Traditional techniques have supported research into finding the physiological changes and hallmarks of cardiovascular aging, including oxidative stress, disabled macroautophagy, loss of proteostasis, and epigenetic alterations, among others. The advent of high-throughput multi-omics techniques offers new perspectives on the molecular mechanisms and cellular processes in the heart, guiding the development of therapeutic targets. This review explores the contributions and characteristics of these high-throughput techniques to unraveling heart aging. We discuss how different high-throughput omics approaches, both alone and in combination, produce robust and exciting new findings and outline future directions and prospects in studying heart aging in this new era.

14 July 2023 in eLife
Verified
Journal Article
Open access
BSBrian Spurlock
Brian Spurlock
Li QianLi Qian
Li Qian
Newly developed tools will help researchers understand how the human heart develops and build better models to study and treat congenital heart disease.

3 October 2023 in Current Opinion in Genetics & Development
Verified
Journal Article
Closed access
BSBrian Spurlock
Brian Spurlock
Jiandong LiuJiandong Liu
Jiandong Liu
Li QianLi Qian
Li Qian

5 March 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
BSBrian Spurlock
Brian Spurlock
DPD Parker
D Parker
MBMk Basu
Mk Basu
AHA Hjelmeland
A Hjelmeland
GSG Sajina
G Sajina
KMK Mitra
K Mitra
The opposing processes of mitochondrial fission and fusion are emerging as crucial regulators of stemness. Gene knockout of the master regulator of mitochondrial fission, Drp1, prevents neoplastic transformation. However, stem/progenitor cells maintaining repressed mitochondrial fission are primed for self-renewal and proliferation. Here, we demonstrate that only fine-tuned repression of Drp1 establishes a ‘stem/progenitor-like state’ towards supporting carcinogen driven neoplastic transformation of keratinocytes, while more complete Drp1 repression prevents it. Only fine-tuned Drp1 repression maintains small networks of fused mitochondria to sustain a unique gene-expression profile with elevated stem/progenitor cell functional markers (Krt15, Sox2 etc) and their regulators (Cyclin E). Cells with such a mitochondria-primed state are slow cycling, susceptible to transformation, and when enriched by mild carcinogen exposure sustains elevated self-renewal/proliferation to form less differentiated tumors. Therefore, our data for the first time highlights a ‘goldilocks’ level of Drp1 repression that supports stem/progenitor state dependent neoplastic transformation.